A citation-based method for searching scientific literature

Ciara Conduit, Roger L Milne, Michael L Friedlander, Kelly-Anne Phillips. Cancer Prev Res (Phila) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
Andrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, Silvia Caviglia, Franca Avino, Laura Cortesi, Cristiana Taverniti, Maria Grazia Pacquola, Fabio Falcini, Marcella Gulisano,[...]. J Clin Oncol 2019
57
100



Breast cancer after bilateral risk-reducing mastectomy.
A-B Skytte, D Crüger, M Gerster, A-V Laenkholm, C Lang, K Brøndum-Nielsen, M K Andersen, L Sunde, S Kølvraa, A-M Gerdes. Clin Genet 2011
32
100

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
230
100

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
100

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
Gemma Molyneux, Felipe C Geyer, Fiona-Ann Magnay, Afshan McCarthy, Howard Kendrick, Rachael Natrajan, Alan Mackay, Anita Grigoriadis, Andrew Tutt, Alan Ashworth,[...]. Cell Stem Cell 2010
468
100

Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).
Phuong L Mai, Austin Miller, Mitchell H Gail, Steven Skates, Karen Lu, Mark E Sherman, Olga B Ioffe, Gustavo Rodriguez, David E Cohn, John Boggess,[...]. JNCI Cancer Spectr 2019
7
100

Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes.
Angela M Wood, Ian R White, Melvyn Hillsdon, James Carpenter. Int J Epidemiol 2005
56
100

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
Fergus J Couch, Xianshu Wang, Lesley McGuffog, Andrew Lee, Curtis Olswold, Karoline B Kuchenbaecker, Penny Soucy, Zachary Fredericksen, Daniel Barrowdale, Joe Dennis,[...]. PLoS Genet 2013
185
100

The rise of multiple imputation: a review of the reporting and implementation of the method in medical research.
Panteha Hayati Rezvan, Katherine J Lee, Julie A Simpson. BMC Med Res Methodol 2015
152
100

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
100


RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Emma Nolan, François Vaillant, Jane E Visvader, Geoffrey J Lindeman. J Natl Cancer Inst 2017
8
100

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.
William D Foulkes, Kelly Metcalfe, Ping Sun, Wedad M Hanna, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Olufunmilayo I Olopade, Barbara L Weber, Jane McLennan,[...]. Clin Cancer Res 2004
220
100

Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.
Jenny Chang-Claude, Nadine Andrieu, Matti Rookus, Richard Brohet, Antonis C Antoniou, Susan Peock, Rosemarie Davidson, Louise Izatt, Trevor Cole, Catherine Noguès,[...]. Cancer Epidemiol Biomarkers Prev 2007
44
100

Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.
Sarah L Ingham, Matthew Sperrin, Andrew Baildam, Gary L Ross, Richard Clayton, Fiona Lalloo, Iain Buchan, Anthony Howell, D Gareth R Evans. Breast Cancer Res Treat 2013
33
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
100

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
211
100

Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.
Roger L Milne, Antonis C Antoniou. Endocr Relat Cancer 2016
37
100

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Nasim Mavaddat, Antonis C Antoniou, Thea M Mooij, Maartje J Hooning, Bernadette A Heemskerk-Gerritsen, Catherine Noguès, Marion Gauthier-Villars, Olivier Caron, Paul Gesta, Pascal Pujol,[...]. Breast Cancer Res 2020
16
100

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
100

Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation.
Hester M Klaren, Laura J van't Veer, Flora E van Leeuwen, Matti A Rookus. J Natl Cancer Inst 2003
57
100

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
868
100

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Christian F Singer, Pal Moller, Henry T Lynch, Susan Armel, Beth Karlan, William D Foulkes, Susan L Neuhausen,[...]. J Natl Cancer Inst 2016
133
100

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.
Ian M Collins, Roger L Milne, Prue C Weideman, Sue-Anne McLachlan, Michael L Friedlander, John L Hopper, Kelly-Anne Phillips. Med J Aust 2013
36
100

Effect of bilateral oophorectomy on mammary tumor formation in BRCA1 mutant mice.
Richard Bachelier, Xiaoling Xu, Cuiling Li, Wenhui Qiao, Priscilla A Furth, Ronald A Lubet, Chu-Xia Deng. Oncol Rep 2005
28
100

Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk.
Mary Beth Terry, Mary B Daly, Kelly Anne Phillips, Xinran Ma, Nur Zeinomar, Nicole Leoce, Gillian S Dite, Robert J MacInnis, Wendy K Chung, Julia A Knight,[...]. J Natl Cancer Inst 2019
20
100


Effect of bilateral oophorectomy on women's long-term health.
William H Parker, Vanessa Jacoby, Donna Shoupe, Walter Rocca. Womens Health (Lond) 2009
87
100

Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
97
100

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.
Kelly Metcalfe, Andrea Eisen, Leigha Senter, Susan Armel, Louise Bordeleau, Wendy S Meschino, Tuya Pal, Henry T Lynch, Nadine M Tung, Ava Kwong,[...]. Br J Cancer 2019
43
100

Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
Xiao Li, Ran You, Xinwei Wang, Congxin Liu, Zicheng Xu, Jin Zhou, Bin Yu, Ting Xu, Hongzhou Cai, Qing Zou. Clin Cancer Res 2016
72
100

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium.
Hongyan Li, Mary Beth Terry, Antonis C Antoniou, Kelly-Anne Phillips, Karin Kast, Thea M Mooij, Christoph Engel, Catherine Noguès, Dominique Stoppa-Lyonnet, Christine Lasset,[...]. Cancer Epidemiol Biomarkers Prev 2020
4
100

Response.
B A M Heemskerk-Gerritsen, M J Hooning, M A Rookus. J Natl Cancer Inst 2015
5
100

Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Morteza Mahdavi, Mohammadreza Nassiri, Mohammad Mahdi Kooshyar, Masoume Vakili-Azghandi, Amir Avan, Ryan Sandry, Suja Pillai, Alfred King-Yin Lam, Vinod Gopalan. J Cell Physiol 2019
23
100

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.
B A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, M M A Tilanus-Linthorst, L B Koppert, I M A Obdeijn, C H M van Deurzen, J M Collée, C Seynaeve, M J Hooning. Ann Oncol 2013
64
100

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
119
100

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Chuying Wang, Feng Bai, Li-Han Zhang, Alexandria Scott, Enxiao Li, Xin-Hai Pei. Breast Cancer Res 2018
10
100

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Mark Robson, Martee Hensley, Richard Barakat, Carol Brown, Dennis Chi, Elizabeth Poynor, Kenneth Offit. Gynecol Oncol 2003
98
100

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L Neuhausen, Parviz Ghadirian,[...]. J Clin Oncol 2005
306
100

Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.
Furu Wang, Qiaoqiao Fang, Zhen Ge, Ningle Yu, Sanxiao Xu, Xiangyong Fan. Mol Biol Rep 2012
32
100

Oophorectomy, estrogen, and dementia: a 2014 update.
Walter A Rocca, Brandon R Grossardt, Lynne T Shuster. Mol Cell Endocrinol 2014
115
100

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Daniel R Barnes, Matti A Rookus, Lesley McGuffog, Goska Leslie, Thea M Mooij, Joe Dennis, Nasim Mavaddat, Julian Adlard, Munaza Ahmed, Kristiina Aittomäki,[...]. Genet Med 2020
28
100

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
T R Rebbeck, A M Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, C Isaacs, O Olopade, J E Garber, A K Godwin,[...]. J Natl Cancer Inst 1999
460
100

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.
Walter A Rocca, Brandon R Grossardt, Mariza de Andrade, George D Malkasian, L Joseph Melton. Lancet Oncol 2006
340
100


Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Kelly Metcalfe, Henry T Lynch, William D Foulkes, Nadine Tung, Charmaine Kim-Sing, Olufunmilayo I Olopade, Andrea Eisen, Barry Rosen, Carrie Snyder, Shelley Gershman,[...]. JAMA Oncol 2015
64
100

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
269
100

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Amanda B Spurdle, Olga M Sinilnikova, Sue Healey, Karen A Pooley, Rita K Schmutzler, Beatrix Versmold, Christoph Engel, Alfons Meindl, Norbert Arnold,[...]. Am J Hum Genet 2008
198
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.